-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shisi Pharmaceutical Ranked Among the Top 100 Chinese Chemical Pharmaceutical Companies in 2019
Category:
发布时间：2020-08-26
Shisi Pharmaceutical Ranked Among the Top 100 Chinese Chemical Pharmaceutical Companies in 2019
Ainuoda Arbidol Hydrochloride Capsules Honored as China’s Most Promising Pharmaceutical Brand
The ancient Tea-Horse Road, a land of dazzling splendor, now converges in Wanxiu at the pinnacle of vibrant diversity. On the crisp autumn evening of August 25 in Kunming, the night sky was ablaze with stars as the annual grand event of the pharmaceutical industry unfolded as scheduled at the Yun’an Convention and Exhibition Hotel. Elite representatives from across the nation’s pharmaceutical sector gathered to witness the prestigious unveiling of the “2019 Top 100 Chinese Pharmaceutical Companies” series of rankings. Shisi Pharmaceutical was proudly listed among the Top 100 Chinese Chemical Pharmaceutical Enterprises for 2019, ranking 45th; meanwhile, its flagship product, Ainuoda Arbidol Hydrochloride Capsules, was honored as one of China’s Most Promising Pharmaceutical Brands.
As the “leaders” of China’s pharmaceutical industry, the companies featured on this list were selected by the Expert Committee of the Top 100 Chinese Pharmaceutical Enterprises Ranking, with a focus on firms’ innovation-driven capabilities and their professional promotion strength. Innovation drive is primarily assessed based on comprehensive R&D investment metrics, while professional promotion strength is rigorously defined using end-user quantitative data derived from the ultimate preferences of clinicians and patients. This evaluation is underpinned by the three-terminal, six-market terminal landscape database—developed and maintained for many years by Mene.net—enabling a scientific and rigorous assessment of pharmaceutical enterprises.
In response to the growing international trend toward greater standardization and systematization in China’s pharmaceutical industry, the “2019 Top 100 Chinese Pharmaceutical Companies Series Rankings” has been subdivided into five distinct sub-rankings: the “Top 100 Chinese Chemical Pharmaceutical Companies,” the “Top 100 Chinese Traditional Chinese Medicine Companies,” the “Top 20 Chinese CRO (including CDMO) Companies,” the “Top 20 Chinese Medical Device (including IVD) Companies,” and the “Top 20 Chinese Biopharmaceutical (including blood products, vaccines, insulin, and other biologics) Companies,” thereby providing a comprehensive overview of innovation across the entire industry value chain.
As a major pillar enterprise in China’s pharmaceutical industry, Shisi Pharmaceutical has translated the new development philosophy into concrete strategic initiatives, continuously deepening supply-side reform, optimizing its production–sales structure, fostering synergistic development between its finished dosage forms and active pharmaceutical ingredient segments, and steadily increasing the proportion of new products. The company is advancing rapidly on the path of innovation-driven, green, and high-quality development, garnering widespread attention from both the industry and society.
The message delivered at the press conference to the top 100 pharmaceutical companies was both inspiring and thought-provoking: despite numerous challenges and difficulties, these enterprises have stood the test of time and reaped the honors that are rightfully theirs. There is a kind of pursuit called never giving up; there is a kind of contribution called extraordinary excellence; and there is a kind of success called well-deserved recognition. They have left an indelible mark on the development of the pharmaceutical industry; they have never slackened their efforts, seizing every moment to stay ahead, and have thus become pioneers and leaders in the sector.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code